Role of molecular markers in the diagnosis and therapy of renal cell carcinoma.
about
Accurate molecular classification of renal tumors using microRNA expressionProgression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model.Staging of renal cell carcinoma: Current concepts.Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments.Cannabinoid CB₁ receptor is downregulated in clear cell renal cell carcinoma.Expression of drug targets in primary and matched metastatic renal cell carcinoma tumors.Low adiponectin levels are associated with renal cell carcinoma: a case-control study.The Relationship between B7-H4 Expression and Clinicopathological Characteristics in Clinical Stage T1 Conventional Renal Cell Carcinoma.A vitamin D receptor-alkylating derivative of 1α,25-dihydroxyvitamin D3 inhibits growth of human kidney cancer cells and suppresses tumor growth.The contemporary role of renal mass biopsy in the management of small renal tumors.Cancer/testis antigens and urological malignanciesOncogenic microRNA-142-3p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.Management of locally advanced renal cell carcinoma.Targeted therapy for renal cell carcinoma: a new therapeutic paradigm.Role of carbonic anhydrases in the progression of renal cell carcinoma subtypes: proposal of a unified hypothesis.Current understanding of the molecular mechanisms of kidney cancer: a primer for urologists.The role of molecular markers in the staging of renal cell carcinoma.Prognostic factors in renal cell cancer.Patterns of recurrence and surveillance strategies for renal cell carcinoma following surgical resection.From bench to bedside: current and future applications of molecular profiling in renal cell carcinomaVascular endothelial growth factor gene polymorphisms and renal cell carcinoma: A systematic review and meta-analysis.Dynamic contrast-enhanced magnetic resonance imaging of vascular changes induced by sunitinib in papillary renal cell carcinoma xenograft tumors.pVHL-mediated transcriptional repression of c-Myc by recruitment of histone deacetylases.Nuclear localization of the CK2α-subunit correlates with poor prognosis in clear cell renal cell carcinoma.What can molecular pathology contribute to the management of renal cell carcinoma?The epigenetics of renal cell tumors: from biology to biomarkers.Overexpression of Csk-binding protein contributes to renal cell carcinogenesis.Angiomyolipoma being surgically excised for presumed kidney carcinoma.SCUBE1: a promising biomarker in renal cell cancerIdentification and validation of a 44-gene expression signature for the classification of renal cell carcinomas.von Hippel-Lindau protein promotes Skp2 destabilization on DNA damage.Targeting DNA Methyltranferases in Urological Tumors.
P2860
Q24625843-5BB43115-FD55-40FB-912A-CBA177C45EEEQ33268699-94920D6D-C7AD-4BF9-ACDC-8230648261DCQ33599726-BD576E8D-0F19-4484-A6D5-94B9498D6824Q33712944-F6CD4396-D526-4CB8-83C7-2C57800727F6Q34338079-8B1232DF-2882-4C5C-A9DC-55D76ADF58E6Q34572309-DBE6CC0C-964D-47B5-8601-9E7E89D04CC5Q34598247-A5BC1443-3425-4B31-949C-102BEB596D9EQ34609867-7DDAEC4D-76DE-49F6-ACBF-7183B5FD9499Q34689137-9634DF40-6577-4766-96D1-9005D85274A6Q36220608-34D27F59-CA63-4B59-AB3C-5DB6981E5059Q36337004-0E3A125E-193A-4DDE-A1DD-D51D654B911FQ36524578-5E6AF29A-8BDC-4E42-AA83-6075AC837E52Q36555667-CA7707EE-902B-4F4D-BDBD-1837CD6977F2Q36597063-1B5FF2E3-A098-4EC4-A799-73A7CE22049AQ36680692-6C1F4A76-C148-45D0-BB2E-BF7D254CFE13Q36710400-43DD4870-6EB1-4940-9624-71BB6DD4BF80Q36794752-2889B66D-23EE-4139-8800-6A3C120F6463Q36794803-3DB92E34-789F-42A6-B6B5-75C7AD349679Q36842777-F95E4FFD-CA7D-44AD-B63A-64FD52D8E50EQ37154789-EEA90839-EE41-4443-8CDC-5A231CBCC48BQ37229446-2C3698A7-00D2-4A74-A8FE-FA5196C99526Q37328130-E77BF510-2DA9-495A-9E48-AA892743123EQ37461503-C46588D3-8373-4005-A171-F6F2B895775BQ37702141-E1325AF7-6466-4597-B7BC-47EE5B1A2F97Q37864528-35222BF7-A6CC-484E-9396-15396FAA6B43Q38016153-5D81DDA4-2ED1-4CE4-978D-D8DA243A01CDQ39828303-366191CE-348C-48CD-A2F2-A62D1C0F62FCQ40977828-9FA8F8EC-C4BB-4ADA-9E4B-44E87A540622Q41412069-7F4420EB-5C84-4315-8F8A-001C0317C318Q47104226-CF1C916B-AE70-48C3-8A2C-E9FE8071DCE0Q54609264-3E68DE2D-97CB-40F7-BA64-4CBF1ABA0C4FQ55435258-D9F25023-6852-4D40-BCEE-C2857C3DBC4D
P2860
Role of molecular markers in the diagnosis and therapy of renal cell carcinoma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Role of molecular markers in the diagnosis and therapy of renal cell carcinoma.
@ast
Role of molecular markers in the diagnosis and therapy of renal cell carcinoma.
@en
type
label
Role of molecular markers in the diagnosis and therapy of renal cell carcinoma.
@ast
Role of molecular markers in the diagnosis and therapy of renal cell carcinoma.
@en
prefLabel
Role of molecular markers in the diagnosis and therapy of renal cell carcinoma.
@ast
Role of molecular markers in the diagnosis and therapy of renal cell carcinoma.
@en
P2093
P1433
P1476
Role of molecular markers in the diagnosis and therapy of renal cell carcinoma
@en
P2093
Arie S Belldegrun
John S Lam
Robert A Figlin
P356
10.1016/J.UROLOGY.2005.06.112
P407
P433
P577
2005-11-01T00:00:00Z